Os 151 melhores médicos de prostatectomia do mundo

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O médico é um especialista em urologia altamente experiente, atuando como Chefe do Departamento de Urologia no Hospital Quirónsalud Torrevieja desde 2017. Com formação médica e especialização pela Universidade Johannes Gutenberg na Alemanha, o médico possui vasta experiência clínica desde 2007. A especialização do médico abrange urologia oncológica, doenças da próstata e condições complexas do trato urinário.

Um foco principal da prática do médico é a cirurgia urológica robótica, utilizando especificamente o sistema cirúrgico Da Vinci para procedimentos de câncer de próstata. O médico contribuiu para a literatura acadêmica, incluindo capítulos em "Differentialdiagnose Urologie", e mantém um forte compromisso em fornecer atendimento de alta qualidade tanto para pacientes locais quanto internacionais.

A Dra. Jang Hyun Kyung é uma urologista certificada. Concluiu a sua residência e bolsa clínica no Centro Médico Gil da Universidade de Gachon. Posteriormente, serviu como Professora Assistente Clínica de Urologia no Hospital Ansan da Universidade da Coreia e no Hospital Internacional St. Mary.

Os seus interesses clínicos incluem HBP, urolitíase, incontinência urinária e disfunção miccional, e infeções do trato urinário. Também se concentra em urologia masculina, urologia pediátrica e ultrassonografia urológica.

Afiliações profissionais: Membro pleno da Associação Urológica Coreana, da Sociedade Coreana de Continência, da Sociedade Coreana de Urologia Pediátrica, da Associação Coreana de Infeção e Inflamação do Trato Urogenital e da Sociedade Coreana de Ultrassonografia Urológica. Afiliação atual: Urologista, Hospital Gibbeum.

A Dra. Dorit Zilberman é urologista sénior no Sheba Medical Center em Israel. É pioneira em cirurgia urológica robótica e minimamente invasiva. A Dra. Zilberman trata cancros do rim, da bexiga e da próstata. Ajudou a lançar o programa de cirurgia robótica da Vinci em Sheba. A Forbes Israel reconheceu-a entre os melhores médicos do país.

• Autora de mais de 160 publicações científicas em oncologia urológica e endourologia.
• Completou a sua formação de especialização no Duke University Medical Center, nos EUA.
• Realiza prostatectomia robótica, litotripsia a laser e cirurgia conservadora do rim.
• Membro das Associações Urológicas Americana e Europeia e da Endourological Society.

O Dr. Nir Kleinmann dirige a Unidade de Endourologia e Cálculos Renais no Sheba Medical Center. Ele é pioneiro em cirurgia a laser de preservação renal para tumores complexos. A Forbes e a ResultMed nomearam-no entre os melhores médicos de Israel para 2025 e 2026. O Dr. Kleinmann utiliza um sistema de laser duplo exclusivo para preservar a função orgânica durante o tratamento do cancro.

• Completou bolsas de urologia na Universidade Thomas Jefferson e na Universidade McMaster.
• Especialista em tratamentos minimamente invasivos para UTUC, cálculos renais e cancro da próstata.
• Atuou como investigador no ensaio OLYMPUS para quimioablação não cirúrgica.
• Membro da Sociedade Americana de Endourologia com mais de 60 publicações científicas.

Mais de 50 publicações científicas e cargos de liderança no principal centro oncológico de Israel — o Dr. Zohar Dotan é um dos poucos uro-oncologistas em Israel com formação de subespecialização (fellowship).

• Chefe de Urologia no Sheba Medical Center – hospital universitário da Universidade de Tel Aviv
• Pioneiro em técnicas de prostatectomia robótica em Israel
• Vencedor de prémios da Associação Americana de Cirurgia Clínica
• Formado no Memorial Sloan Kettering Cancer Center

O Dr. Ozkan é especializado em doenças da próstata e tratamentos do trato urinário nos hospitais Büyük Anadolu.

• Especialista em prostatectomia e tratamento de tumores na bexiga
• Qualificado no tratamento da incontinência urinária
• Experiente no tratamento da infertilidade e doenças sexuais

O Dr. Vladimir Yutkin traz mais de _doctor_3603_ anos de experiência em prostatectomia no Hadassah Medical Center.

• Formado pela Universidade Hebraica de Jerusalém em 1996
• Especializado em distúrbios da articulação temporomandibular
• Fluente em inglês, hebraico e russo

Especializado em cirurgias de próstata abertas e fechadas – o Dr. Aydogan oferece opções abrangentes de prostatectomia nos hospitais Büyük Anadolu.

• Especialista em cirurgias oncológicas urológicas
• Experiente no tratamento da incontinência urinária
• Realiza RIRS (litotripsia a laser para cálculos renais)

O Prof. Yurdakul especializa-se em uro-oncologia com formação de fellowship na Cleveland Clinic – líder no tratamento do cancro da próstata.

• Realiza prostatectomias com foco em técnicas de preservação nervosa
• Publicou 16 artigos internacionais sobre resultados em uro-oncologia
• Formado em microcirurgia vascular para casos complexos
• Professor na Faculdade de Medicina da Universidade de Selcuk
• Orador em conferências nacionais de urologia

Urologista, cirurgião

O Dr. Ozkan Onuk é professor associado de urologia na Hermes Clinics em Ancara. Ele realiza prostatectomia robótica da Vinci e enucleação da próstata a laser de hólmio (HoLEP). O Dr. Onuk trata a doença de Peyronie, varicocele e urolitíase em uma instituição acreditada pela JCI.

• Realiza cirurgia de preservação renal e nefrectomia para condições renais.
• Utiliza ultrassom focalizado de alta intensidade (HIFU) para ablação de tecidos.
• Especializado em procedimentos reconstrutivos, como uretroplastia e vasectomia.
• Realiza ureterorrenoscopia flexível (URS) para cálculos renais.

O Dr. Daniel Leszczynski é membro do European Board of Urology com experiência em cirurgia urológica laparoscópica.

• Especializado em urologia com anos de experiência em procedimentos laparoscópicos
• Membro da Associação Polaca de Urologia
• Formado no Departamento de Urologia da Universidade Médica de Varsóvia

O Dr. Sertkaya especializa-se em Andrologia, focando-se na saúde reprodutiva e urinária masculina, com uma forte ênfase em procedimentos relacionados com a próstata.

• Urologista certificado com mais de _doctor_5341_ anos de experiência
• Membro do Conselho Europeu de Urologia (FEBU)
• Professor associado de Urologia desde 2020
• Fundador do centro de saúde e estética masculina Andro Expertise

O Dr. Pastrana é um cirurgião oncológico especializado em prostatectomia, com vasta formação nas principais instituições do México.

• Certificado pelo Conacem – a certificação médica mais alta do México
• Membro da Sociedade Mexicana de Oncologia (SMEO)
• Professor universitário na Faculdade de Medicina da Universidade Anahuac desde 2020
• Realizou residência cirúrgica no Instituto Mexicano do Seguro Social

O Dr. Czarniecki dirige o único centro abrangente de diagnóstico e tratamento robótico para o cancro da próstata na Europa Central, tendo realizado mais de 2.500 biópsias de fusão.

• Especializado em urologia oncológica e terapias robóticas para o cancro da próstata
• Utiliza o método HIFU para um tratamento preciso e menos invasivo
• Colabora com centros internacionais líderes nos EUA e na Europa
• Ativo nos comités da Associação Europeia de Urologia
• Coautor de numerosas publicações científicas sobre o diagnóstico do cancro da próstata

O médico é um especialista em urologia altamente experiente, com uma extensa carreira que abrange mais de três décadas. Após se formar na Faculdade de Medicina da Universidade de Uludağ em 1988, o médico completou um programa de especialização em urologia em 1997. O médico alcançou o posto de Professor Associado em 2006 e obteve o título de Professor em 2011.

Ao longo de uma carreira distinta, o médico ocupou inúmeros cargos de liderança, incluindo o de Chefe do Departamento de Urologia em vários hospitais universitários e o de Supervisor Educacional e Administrativo em grandes hospitais de ensino e pesquisa. O médico possui profunda experiência em urologia clínica, tendo atuado em diversas instituições médicas estatais e privadas em toda a Turquia.

O Dr. Tsafrakidis especializa-se em prostatectomia com técnicas robóticas avançadas e minimamente invasivas, garantindo precisão e uma recuperação mais rápida.

• _doctor_9495_anos_ de experiência em urologia
• Investigador principal em estudos de biópsia da próstata
• Membro do Conselho Europeu de Urologia
• Professor sénior honorário na Universidade de St Andrews
• Realiza procedimentos urológicos de rotina e complexos duas vezes por semana